KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Nektar Therapeutics (NKTR) Interest Coverage Ratio (2016 - 2020)

Historic Interest Coverage Ratio for Nektar Therapeutics (NKTR) over the last 11 years, with Q2 2020 value amounting to 120.11.

  • Nektar Therapeutics' Interest Coverage Ratio fell 46616.91% to 120.11 in Q2 2020 from the same period last year, while for Mar 2021 it was 619.59, marking a year-over-year decrease of 294855.81%. This contributed to the annual value of 62.05 for FY2020, which is 20050.01% down from last year.
  • Nektar Therapeutics' Interest Coverage Ratio amounted to 120.11 in Q2 2020, which was down 46616.91% from 21.54 recorded in Q1 2020.
  • In the past 5 years, Nektar Therapeutics' Interest Coverage Ratio ranged from a high of 180.8 in Q2 2018 and a low of 120.11 during Q2 2020
  • For the 5-year period, Nektar Therapeutics' Interest Coverage Ratio averaged around 7.09, with its median value being 13.16 (2017).
  • Its Interest Coverage Ratio has fluctuated over the past 5 years, first crashed by 597731.16% in 2016, then skyrocketed by 206659.79% in 2018.
  • Nektar Therapeutics' Interest Coverage Ratio (Quarter) stood at 5.79 in 2016, then increased by 26.33% to 4.27 in 2017, then plummeted by 334.1% to 18.52 in 2018, then decreased by 9.05% to 20.2 in 2019, then tumbled by 494.63% to 120.11 in 2020.
  • Its Interest Coverage Ratio was 120.11 in Q2 2020, compared to 21.54 in Q1 2020 and 20.2 in Q4 2019.